161 Fort Washington AveNew York, NY 10032
Overview of Dr. Mundi
Dr. Prabhjot Mundi is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and James J. Peters Veterans Affairs Medical Center. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 8 years. He is one of 384 doctors at New York-Presbyterian Hospital and one of 119 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He has more than 20 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2013 - 2016
Boston University Medical CenterResidency, Internal Medicine, 2010 - 2013
State University of New York Downstate Medical Center College of MedicineClass of 2009
Certifications & Licensure
NY State Medical License 2013 - 2026
MA State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.Yaniv Kazansky, Helen S Mueller, Daniel Cameron, Phillip Demarest, Nadia Zaffaroni
The Journal of Clinical Investigation. 2025-10-15 - Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.Yaniv Kazansky, Helen S Mueller, Daniel Cameron, Phillip Demarest, Nadia Zaffaroni
Biorxiv. 2025-03-07 - 1 citationsIdentification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy.Jeremy Worley, Heeju Noh, Daoqi You, Mikko M Turunen, Hongxu Ding
Biorxiv. 2025-02-12
Abstracts/Posters
- Casein Kinase 1 Delta Is a Novel Regulator of mRNA Translation and Druggable Target in Aggressive LymphomasPrabhjot S. Mundi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Targeting eIF4A Using MZ-735 Potently Induces Cell Death in Lymphoma Cells and Rapidly Represses mRNA Translation at the Global Level and in C-MYC and Other OncogenesPrabhjot S. Mundi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
